Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoko Kojima

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Hinyokika Kiyo. Acta Urologica Japonica|July 17, 2007
[The clinical efficacy of SNRI milnacipran in the treatment of hot flushes with prostate cancer hormonally treated]Hiroyoshi Suzuki, Akira Komiya, Satoko Kojima, et al.
Urology Case Reports|May 3, 2017
Severe Hypophosphatemia Following Denosumab Administration in a Hemodialysis Patient with Progressive Prostate CancerHiroshi Masuda, Kanya Kaga, Masahiko Inahara, et al.
Hinyokika Kiyo. Acta Urologica Japonica|July 17, 2007
A case of venous air embolism during transurethral resection of the prostateDaisuke Matsuno, Shuko Cho, Shinzo Isshiki, et al.
Prostate Cancer|April 26, 2021
High Serum Alkaline Phosphatase Flare after First-Line Androgen Deprivation Therapy Predicts Poor Prognosis in Metastatic Prostate Cancer Patients Treated with Second-Generation Androgen Receptor Targeted TherapySatoko Kojima, Hiroshi Masuda, Takahito Suyama, et al.
The Prostate|March 17, 2006
Differential regulation of IGFBP-3 by the androgen receptor in the lineage-related androgen-dependent LNCaP and androgen-independent C4-2 prostate cancer modelsSatoko Kojima, David J Mulholland, Susan Ettinger, et al.
British Journal of Cancer|April 13, 2016
Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancerYusuke Goto, Satoko Kojima, Akira Kurozumi, et al.
Cancer Diagnosis & Prognosis|April 11, 2022
Successful Response to Nivolumab Plus Ipilimumab Therapy in a Hemodialysis Patient With Metastatic Renal Cell CarcinomaHiroshi Masuda, Kosuke Mikami, Kotaro Otsuka, et al.
In Vivo (Athens, Greece)|April 29, 2021
Validation of the Effectiveness of Neutrophil-to-lymphocyte Ratio (NLR) as a Predictive Factor in Patients Undergoing Prostate Biopsy With Prostate Specific Antigen (PSA) Between 4.0 and 10.0 ng/mlHiroshi Masuda, Kosuke Mikami, Kotaro Otsuka, et al.
European Urology|September 29, 2006
The clinical potential of pretreatment serum testosterone level to improve the efficiency of prostate cancer screeningMasashi Yano, Takashi Imamoto, Hiroyoshi Suzuki, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|December 28, 2022
The choice of therapeutic agent in female overactive bladder patients in real-world practiceHiroshi Masuda, Kosuke Mikami, Kotaro Otsuka, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Hinyokika Kiyo. Acta Urologica Japonica|July 17, 2007
[The clinical efficacy of SNRI milnacipran in the treatment of hot flushes with prostate cancer hormonally treated]Hiroyoshi Suzuki, Akira Komiya, Satoko Kojima, et al.
Urology Case Reports|May 3, 2017
Severe Hypophosphatemia Following Denosumab Administration in a Hemodialysis Patient with Progressive Prostate CancerHiroshi Masuda, Kanya Kaga, Masahiko Inahara, et al.
Hinyokika Kiyo. Acta Urologica Japonica|July 17, 2007
A case of venous air embolism during transurethral resection of the prostateDaisuke Matsuno, Shuko Cho, Shinzo Isshiki, et al.
Prostate Cancer|April 26, 2021
High Serum Alkaline Phosphatase Flare after First-Line Androgen Deprivation Therapy Predicts Poor Prognosis in Metastatic Prostate Cancer Patients Treated with Second-Generation Androgen Receptor Targeted TherapySatoko Kojima, Hiroshi Masuda, Takahito Suyama, et al.
The Prostate|March 17, 2006
Differential regulation of IGFBP-3 by the androgen receptor in the lineage-related androgen-dependent LNCaP and androgen-independent C4-2 prostate cancer modelsSatoko Kojima, David J Mulholland, Susan Ettinger, et al.
British Journal of Cancer|April 13, 2016
Regulation of E3 ubiquitin ligase-1 (WWP1) by microRNA-452 inhibits cancer cell migration and invasion in prostate cancerYusuke Goto, Satoko Kojima, Akira Kurozumi, et al.
Cancer Diagnosis & Prognosis|April 11, 2022
Successful Response to Nivolumab Plus Ipilimumab Therapy in a Hemodialysis Patient With Metastatic Renal Cell CarcinomaHiroshi Masuda, Kosuke Mikami, Kotaro Otsuka, et al.
In Vivo (Athens, Greece)|April 29, 2021
Validation of the Effectiveness of Neutrophil-to-lymphocyte Ratio (NLR) as a Predictive Factor in Patients Undergoing Prostate Biopsy With Prostate Specific Antigen (PSA) Between 4.0 and 10.0 ng/mlHiroshi Masuda, Kosuke Mikami, Kotaro Otsuka, et al.
European Urology|September 29, 2006
The clinical potential of pretreatment serum testosterone level to improve the efficiency of prostate cancer screeningMasashi Yano, Takashi Imamoto, Hiroyoshi Suzuki, et al.
Archivio Italiano Di Urologia, Andrologia : Organo Ufficiale [Di] Societa Italiana Di Ecografia Urologica E Nefrologica|December 28, 2022
The choice of therapeutic agent in female overactive bladder patients in real-world practiceHiroshi Masuda, Kosuke Mikami, Kotaro Otsuka, et al.
Pageof 8